Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.03 is 65% below its 2-year average of 0.09, near the low end of its 2-year range (0.00–0.32).
As of the fiscal period ended Tuesday, June 30, 2026. 66.26% below its 12-month average of 0.09.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.03.
QUICK RATIO (ACID-TEST)
0.03
QUICK RATIO (ACID-TEST) AVG TTM
0.09
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-66.26%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-99.11%
vs the sector median at left
Profusa, Inc. Common Stock
Market Cap
$1.83M
Quick Ratio (Acid-Test)
0.03
TTM Avg
0.09
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.84M
Quick Ratio (Acid-Test)
3.12
TTM Avg
3.16
3Y Avg
3.22
5Y Avg
5.13
Market Cap
$1.84M
Quick Ratio (Acid-Test)
0.48
TTM Avg
2.93
3Y Avg
2.61
5Y Avg
1.85
Market Cap
$1.81M
Quick Ratio (Acid-Test)
0.77
TTM Avg
3.21
3Y Avg
3.08
5Y Avg
4.05
Market Cap
$1.88M
Quick Ratio (Acid-Test)
1.97
TTM Avg
4.42
3Y Avg
2.96
5Y Avg
3.81
Market Cap
$1.88M
Quick Ratio (Acid-Test)
4.85
TTM Avg
5.04
3Y Avg
6.52
5Y Avg
9.62
Market Cap
$1.64M
Quick Ratio (Acid-Test)
5.36
TTM Avg
7.82
3Y Avg
13.02
5Y Avg
13.86
Market Cap
$2.13M
Quick Ratio (Acid-Test)
1.54
TTM Avg
2.65
3Y Avg
3.41
5Y Avg
4.73
Market Cap
$2.14M
Quick Ratio (Acid-Test)
0.21
TTM Avg
0.87
3Y Avg
0.72
5Y Avg
1.52
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.83M | 0.03 | 0.09 | N/A | N/A |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | 3.12 | 3.16 | 3.22 | 5.13 |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | 0.48 | 2.93 | 2.61 | 1.85 |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | 0.77 | 3.21 | 3.08 | 4.05 |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | 1.97 | 4.42 | 2.96 | 3.81 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 4.85 | 5.04 | 6.52 | 9.62 |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | 5.36 | 7.82 | 13.02 | 13.86 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | 1.54 | 2.65 | 3.41 | 4.73 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 0.21 | 0.87 | 0.72 | 1.52 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | 7.70 | 0.13 | 0.13 | 0.13 |
Quick Ratio
0.03
Excludes inventory
Current Ratio
0.03
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.03 |
| 2026-03-31 | 0.02 |
| 2025-12-31 | 0.17 |
| 2025-09-30 | 0.18 |
| 2025-06-30 | 0.04 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.13 |
| 2024-06-30 | 0.03 |
| 2024-03-31 | 0.02 |
| 2023-12-31 | 0.32 |
